Genzyme Genetics Announces the Addition of Spinal Muscular Atrophy (SMA) Testing to Genzyme Genetics’ Comprehensive Carrier Test Menu
Genzyme Genetics now offers accurate, fast carrier testing and prenatal diagnosis for SMA, the most common inherited cause of infant mortality. Learn more about SMA by visiting GeneTests or the Claire Altman Heine Foundation. Learn more about Genzyme’s SMA tests.
Genzyme Genetics Announces the Addition of KRAS Mutation Analysis in Colorectal Cancer
Genzyme Genetics now offers KRAS mutation analysis in colorectal cancer. Detection of KRAS gene mutations helps physicians identify patients who are most likely to show limited clinical response to targeted anti-epidermal growth factor receptor (anti-EGFR) therapies. Learn more about KRAS testing in colorectal cancer and non-small cell lung cancer.
New Book Available - “Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies”
Reviews chromosomal and molecular changes in hematologic malignancies and correlates the karyotypic and genetic abnormalities with morphology, immunophenotype and clinical data. Essential reading for all pathologists, hematopathologists, hematologic oncologists, cytogenetists, cytogenetic technologists and cell biologists. Learn more
| 
Genzyme Corporate
Genetics Home
